SANDRA CHRISTENSEN: Open Payments
NPI 1376606699 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$85,469 in 118 payments from 4 companies in 2025. Trend: 2023 $28,205 · 2024 $85,443 · 2025 $85,469
Speaker / faculty: $45,702Consulting: $24,960Travel & lodging: $12,853Food & beverage: $1,954
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 54 | $50,581 |
| Lilly USA, LLC | 50 | $22,084 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $12,751 |
| Currax Pharmaceuticals LLC | 1 | $53 |
Products named: Wegovy, ZEPBOUND, CONTRAVE.
Industry payments across WA — which companies pay providers there.
